Position in ARWR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$784,941
-$2,668,575 QoQ
Shares Held
9,630
-82.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#258
of 497 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. ARWR ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
254,408 | $28,839,690 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
389,155 | $6,771,297 | |
| 3 | EXEL |
Exelixis, Inc.
|
99,834 | $5,431,967 | |
| 4 | TECH |
BIO-TECHNE Corp
|
67,227 | $4,749,587 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
60,348 | $4,723,437 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
90,546 | $3,532,199 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,880 | $2,372,116 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
106,852 | $1,992,789 |
All Filings in ARWR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $784,941 | 9,630 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,453,516 | 55,080 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $523,883 | 7,891 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $998,313 | 28,945 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $660,092 | 41,778 | Shares | Sole | 2025-08-14 | |
| 2021-09-30 | $376,452 | 6,030 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $377,824 | 4,562 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||